CobelliC, RenardE, KovatchevBP, Keith-HynesP, Ben BrahimN, PlaceJ, Del FaveroS, BretonM, FarretA, BruttomessoD, DassauE, ZisserH, DoyleFJIII, PatekSD, AvogaroA. Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care, 2012; 35(9): e65–e67.
2.
MurphyHR. 21st century diabetes care: a marriage between humans and technology. Trends Endocrinol Metab, 2013; 24(5): 219–21.
3.
NimriR, DanneT, KordonouriO, AtlasE, BratinaN, BiesterT, AvbeljM, MillerS, MullerI, PhillipM, BattelinoT. The “Glucositter” overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatr Diabetes, 2013; 14(3): 159–67.
4.
CapozziD, LanzolaG. A generic telemedicine infrastructure for monitoring an artificial pancreas trial. Comput Methods Programs Biomed, 2013; 110(3): 343–53.
5.
KowalskiAJ, DuttaS. It's time to move from the A1c to better metrics for diabetes control. Diabetes Technol Ther, 2013; 15(3): 194–96.
6.
LeeJJ, DassauE, ZisserH, HarveyRA, JovanovicL, DoyleFJIII. In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control. J Diabetes Sci Technol, 2013; 7(1): 215–26.
